Bliss GVS Pharma Limited (BLISSGVS.NS)
NSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹639.25 (+3.10%) as of
Key statistics
- Market cap
- 68.01B
- P/E (TTM)
- 50.73
- EPS (TTM)
- 12.60
- Dividend yield
- 0.24%
- 52-week range
- 118.00 – 739.90
- Beta
- 1.22
- Revenue (TTM)
- 10.05B
- Profit margin
- 13.55%
- Volume
- 85.96k
About Bliss GVS Pharma Limited
Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. The company offers anti-diabetic, anti-infective, anti-inflammatory, antifungal, antihemorrhoidal, antimalarial, antiseptic, cardiovascular, dermatological, gastrointestinal, gynaecology, neoro/cns, ophthalmic, otc drugs, respiratory, urology, and supplementary drug products, as well as engages in pain management services. It exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Mumbai, India
- Employees
- 1,033
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- JAIN IRRIGATION SYSTEMS (JISLJALEQS.NS)
- AVANTI FEEDS LIMITED (AVANTIFEED.NS)
- Dixon Technologies (India) Lim (DIXON.BO)
- ORACLE FINANCIAL SERVICES SOFT (OFSS.BO)
- TD POWER SYSTEMS LTD. (TDPOWERSYS.NS)
- KAYNES TECHNOLOGY INDIA LIMITE (KAYNES.BO)
- MAN INFRA LTD (MANINFRA.NS)
- KIRLOSKAR BROTHERS LTD (KIRLOSBROS.NS)